-
1
-
-
0028908929
-
The number needed to treat: a clinically useful measure of treatment effect
-
Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ. 1995;310(6977):452-454.
-
(1995)
BMJ
, vol.310
, Issue.6977
, pp. 452-454
-
-
Cook, R.J.1
Sackett, D.L.2
-
2
-
-
81855206806
-
Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force
-
Chou R, Croswell JM, Dana T, Bougatsos C, et al. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. Ann Internal Med. 2011;155(11):762-771.
-
(2011)
Ann Internal Med
, vol.155
, Issue.11
, pp. 762-771
-
-
Chou, R.1
Croswell, J.M.2
Dana, T.3
Bougatsos, C.4
-
3
-
-
79955705831
-
SPCG-4 Investigators. Radical prostatectomy versus watchful waiting in early prostate cancer
-
Bill-Axelson A, Holmberg L, Ruutu M, et al; SPCG-4 Investigators. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2011;364(18):1708-1717.
-
(2011)
N Engl J Med
, vol.364
, Issue.18
, pp. 1708-1717
-
-
Bill-Axelson, A.1
Holmberg, L.2
Ruutu, M.3
-
4
-
-
33646360629
-
Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891
-
Studer UE, Whelan P, Albrecht W, et al. Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891. J Clin Oncol. 2006;24(12):1868-1876.
-
(2006)
J Clin Oncol
, vol.24
, Issue.12
, pp. 1868-1876
-
-
Studer, U.E.1
Whelan, P.2
Albrecht, W.3
-
5
-
-
0033118553
-
CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA results. Canadian Urologic Oncology Group
-
Klotz LH, Goldenberg SL, Jewett M, et al. CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA results. Canadian Urologic Oncology Group. Urology. 1999;53(4):757-763.
-
(1999)
Urology
, vol.53
, Issue.4
, pp. 757-763
-
-
Klotz, L.H.1
Goldenberg, S.L.2
Jewett, M.3
-
6
-
-
0032412924
-
Hormonal treatment before radical prostatectomy: a 3-year followup
-
discussion 2016
-
Aus G, Abrahamsson PA, Ahlgren G, et al. Hormonal treatment before radical prostatectomy: a 3-year followup. J Urol. 1998;159(6):2013-2016; discussion 2016.
-
(1998)
J Urol
, vol.159
, Issue.6
, pp. 2013-2016
-
-
Aus, G.1
Abrahamsson, P.A.2
Ahlgren, G.3
-
7
-
-
0036135882
-
Lupron Depot Neoadjuvant Prostate Cancer Study Group. Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-year results
-
Soloway MS, Pareek K, Sharifi R, et al; Lupron Depot Neoadjuvant Prostate Cancer Study Group. Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-year results. J Urol. 2002;167(1):112-116.
-
(2002)
J Urol
, vol.167
, Issue.1
, pp. 112-116
-
-
Soloway, M.S.1
Pareek, K.2
Sharifi, R.3
-
8
-
-
0033662583
-
4-Year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer. European Study Group on Neoadjuvant Treatment of Prostate Cancer
-
Schulman CC, Debruyne FM, Forster G, Selvaggi FP, Zlotta AR, Witjes WP. 4-Year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer. European Study Group on Neoadjuvant Treatment of Prostate Cancer. Eur Urol. 2000;38(6):706-713.
-
(2000)
Eur Urol
, vol.38
, Issue.6
, pp. 706-713
-
-
Schulman, C.C.1
Debruyne, F.M.2
Forster, G.3
Selvaggi, F.P.4
Zlotta, A.R.5
Witjes, W.P.6
-
9
-
-
8244227327
-
Preoperative endocrine therapy for clinical stage A2, B, and C prostate cancer: an interim report on short-term effects. Prostate Cancer Study Group
-
Homma Y, Akaza H, Okada K, et al. Preoperative endocrine therapy for clinical stage A2, B, and C prostate cancer: an interim report on short-term effects. Prostate Cancer Study Group. Int J Urol. 1997;4(2):144-151.
-
(1997)
Int J Urol
, vol.4
, Issue.2
, pp. 144-151
-
-
Homma, Y.1
Akaza, H.2
Okada, K.3
-
10
-
-
0029016831
-
Neoadjuvant hormonal therapy before radical prostatectomy decreases the number of positive surgical margins in stage T2 prostate cancer: interim results of a prospective randomized trial. The Belgian Uro-Oncological Study Group
-
Van Poppel H, De Ridder D, Elgamal AA, et al. Neoadjuvant hormonal therapy before radical prostatectomy decreases the number of positive surgical margins in stage T2 prostate cancer: interim results of a prospective randomized trial. The Belgian Uro-Oncological Study Group. J Urol. 1995;154(2 pt 1):429-434.
-
(1995)
J Urol
, vol.154
, Issue.2 PART 1
, pp. 429-434
-
-
Van Poppel, H.1
De Ridder, D.2
Elgamal, A.A.3
-
11
-
-
0033540004
-
Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer
-
Messing EM, Manola J, Sarosdy M, Wilding G, Crawford ED, Trump D. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med. 1999;341(24):1781-1788.
-
(1999)
N Engl J Med
, vol.341
, Issue.24
, pp. 1781-1788
-
-
Messing, E.M.1
Manola, J.2
Sarosdy, M.3
Wilding, G.4
Crawford, E.D.5
Trump, D.6
-
12
-
-
59549095954
-
Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial
-
Thompson IM, Tangen CM, Paradelo J, et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol. 2009;181(3):956-962.
-
(2009)
J Urol
, vol.181
, Issue.3
, pp. 956-962
-
-
Thompson, I.M.1
Tangen, C.M.2
Paradelo, J.3
-
13
-
-
67649992725
-
Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95
-
Wiegel T, Bottke D, Steiner U, et al. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol. 2009;27(18):2924-2930.
-
(2009)
J Clin Oncol
, vol.27
, Issue.18
, pp. 2924-2930
-
-
Wiegel, T.1
Bottke, D.2
Steiner, U.3
-
14
-
-
23744493443
-
European Organization for Research and Treatment of Cancer. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)
-
Bolla M, van Poppel H, Collette L, et al; European Organization for Research and Treatment of Cancer. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet. 2005;366(9485):572-578.
-
(2005)
Lancet
, vol.366
, Issue.9485
, pp. 572-578
-
-
Bolla, M.1
van Poppel, H.2
Collette, L.3
-
15
-
-
31944450491
-
More favorable tumor features and progression-free survival rates in a longitudinal prostate cancer screening study: PSA era and threshold-specific effects
-
Jang TL, Han M, Roehl KA, Hawkins SA, Catalona WJ. More favorable tumor features and progression-free survival rates in a longitudinal prostate cancer screening study: PSA era and threshold-specific effects. Urology. 2006;67(2):343-348.
-
(2006)
Urology
, vol.67
, Issue.2
, pp. 343-348
-
-
Jang, T.L.1
Han, M.2
Roehl, K.A.3
Hawkins, S.A.4
Catalona, W.J.5
-
16
-
-
0019983086
-
Radical surgery versus radiotherapy for adenocarcinoma of the prostate
-
Paulson DF, Lin GH, Hinshaw W, Stephani S. Radical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol. 1982;128(3):502-504.
-
(1982)
J Urol
, vol.128
, Issue.3
, pp. 502-504
-
-
Paulson, D.F.1
Lin, G.H.2
Hinshaw, W.3
Stephani, S.4
-
17
-
-
33947513220
-
Japanese Study Group for Locally Advanced Prostate Cancer. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months
-
Akakura K, Suzuki H, Ichikawa T, et al; Japanese Study Group for Locally Advanced Prostate Cancer. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months. Jpn J Clin Oncol. 2006;36(12):789-793.
-
(2006)
Jpn J Clin Oncol
, vol.36
, Issue.12
, pp. 789-793
-
-
Akakura, K.1
Suzuki, H.2
Ichikawa, T.3
-
18
-
-
39149143059
-
Randomized trial comparing cryoablation and external beam radiotherapy for T2C-T3B prostate cancer
-
Chin JL, Ng CK, Touma NJ, et al. Randomized trial comparing cryoablation and external beam radiotherapy for T2C-T3B prostate cancer. Prostate Cancer Prostatic Dis. 2008;11(1):40-45.
-
(2008)
Prostate Cancer Prostatic Dis
, vol.11
, Issue.1
, pp. 40-45
-
-
Chin, J.L.1
Ng, C.K.2
Touma, N.J.3
-
19
-
-
75649127997
-
A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer
-
Donnelly BJ, Saliken JC, Brasher PM, et al. A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer. Cancer. 2010;116(2):323-330.
-
(2010)
Cancer
, vol.116
, Issue.2
, pp. 323-330
-
-
Donnelly, B.J.1
Saliken, J.C.2
Brasher, P.M.3
-
20
-
-
79952701542
-
Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer, Who dies of disease?
-
Kuban DA, Levy LB, Cheung MR, et al. Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease? Int J Radiat Oncol Biol Phys. 2011;79(5):1310-1317.
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.79
, Issue.5
, pp. 1310-1317
-
-
Kuban, D.A.1
Levy, L.B.2
Cheung, M.R.3
-
21
-
-
33646462895
-
Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy
-
Peeters ST, Heemsbergen WD, Koper PC, et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol. 2006;24(13):1990-1996.
-
(2006)
J Clin Oncol
, vol.24
, Issue.13
, pp. 1990-1996
-
-
Peeters, S.T.1
Heemsbergen, W.D.2
Koper, P.C.3
-
22
-
-
34249316816
-
RT01 collaborators. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial
-
Dearnaley DP, Sydes MR, Graham JD, et al; RT01 collaborators. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol. 2007;8(6):475-487.
-
(2007)
Lancet Oncol
, vol.8
, Issue.6
, pp. 475-487
-
-
Dearnaley, D.P.1
Sydes, M.R.2
Graham, J.D.3
-
23
-
-
79959335126
-
70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial
-
Beckendorf V, Guerif S, Le Prisé E, et al. 70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial. Int J Radiat Oncol Biol Phys. 2011;80(4):1056-1063.
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.80
, Issue.4
, pp. 1056-1063
-
-
Beckendorf, V.1
Guerif, S.2
Le Prisé, E.3
-
24
-
-
14544289582
-
Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate
-
Sathya JR, Davis IR, Julian JA, et al. Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate. J Clin Oncol. 2005;23(6):1192-1199.
-
(2005)
J Clin Oncol
, vol.23
, Issue.6
, pp. 1192-1199
-
-
Sathya, J.R.1
Davis, I.R.2
Julian, J.A.3
-
25
-
-
77949509341
-
Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/American college of radiology 95-09
-
Zietman AL, Bae K, Slater JD, et al. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/American college of radiology 95-09. J Clin Oncol. 2010;28(7):1106-1111.
-
(2010)
J Clin Oncol
, vol.28
, Issue.7
, pp. 1106-1111
-
-
Zietman, A.L.1
Bae, K.2
Slater, J.D.3
-
26
-
-
0028910506
-
Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone
-
Shipley WU, Verhey LJ, Munzenrider JE, et al. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys. 1995;32(1):3-12.
-
(1995)
Int J Radiat Oncol Biol Phys
, vol.32
, Issue.1
, pp. 3-12
-
-
Shipley, W.U.1
Verhey, L.J.2
Munzenrider, J.E.3
-
27
-
-
24944526722
-
Randomized trial comparing two fractionation schedules for patients with localized prostate cancer
-
Lukka H, Hayter C, Julian JA, et al. Randomized trial comparing two fractionation schedules for patients with localized prostate cancer. J Clin Oncol. 2005;23(25):6132-6138.
-
(2005)
J Clin Oncol
, vol.23
, Issue.25
, pp. 6132-6138
-
-
Lukka, H.1
Hayter, C.2
Julian, J.A.3
-
28
-
-
77953961599
-
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer
-
Arcangeli G, Saracino B, Gomellini S, Petrongari MG, et al. A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2010;78(1):11-18.
-
(2010)
Int J Radiat Oncol Biol Phys
, vol.78
, Issue.1
, pp. 11-18
-
-
Arcangeli, G.1
Saracino, B.2
Gomellini, S.3
Petrongari, M.G.4
-
29
-
-
84855308494
-
Five year results of a randomized external beam radiotherapy hypofractionation trial for prostate cancer
-
Pollack A, Walker G, Buyounouski M, Horwitz E, et al. Five year results of a randomized external beam radiotherapy hypofractionation trial for prostate cancer. Int J Radiation Oncol Biol Phys. 2011;81(2)(suppl):S1.
-
(2011)
Int J Radiation Oncol Biol Phys
, vol.81
, Issue.SUPPL. 2
-
-
Pollack, A.1
Walker, G.2
Buyounouski, M.3
Horwitz, E.4
-
30
-
-
0022364149
-
Fast neutron radiotherapy for locally advanced prostate cancer: results of an RTOG randomized study
-
Laramore GE, Krall JM, Thomas FJ, Griffin TW, Maor MH, Hendrickson FR. Fast neutron radiotherapy for locally advanced prostate cancer: results of an RTOG randomized study. Int J Radiat Oncol Biol Phys. 1985;11(9):1621-1627.
-
(1985)
Int J Radiat Oncol Biol Phys
, vol.11
, Issue.9
, pp. 1621-1627
-
-
Laramore, G.E.1
Krall, J.M.2
Thomas, F.J.3
Griffin, T.W.4
Maor, M.H.5
Hendrickson, F.R.6
-
31
-
-
0027979776
-
Photon versus fast neutron external beam radiotherapy in the treatment of locally advanced prostate cancer: results of a randomized prospective trial
-
Russell KJ, Caplan RJ, Laramore GE, et al. Photon versus fast neutron external beam radiotherapy in the treatment of locally advanced prostate cancer: results of a randomized prospective trial. Int J Radiat Oncol Biol Phys. 1994;28(1):47-54.
-
(1994)
Int J Radiat Oncol Biol Phys
, vol.28
, Issue.1
, pp. 47-54
-
-
Russell, K.J.1
Caplan, R.J.2
Laramore, G.E.3
-
32
-
-
0036435605
-
Fast neutron irradiation for prostate cancer
-
Forman JD, Yudelev M, Bolton S, Tekyi-Mensah S, Maughan R. Fast neutron irradiation for prostate cancer. Cancer Metastasis Rev. 2002;21(2):131-135.
-
(2002)
Cancer Metastasis Rev
, vol.21
, Issue.2
, pp. 131-135
-
-
Forman, J.D.1
Yudelev, M.2
Bolton, S.3
Tekyi-Mensah, S.4
Maughan, R.5
-
33
-
-
0344395011
-
125I versus 103Pd for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial
-
Wallner K, Merrick G, True L, Sutlief S, Cavanagh W, Butler W. 125I versus 103Pd for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial. Int J Radiat Oncol Biol Phys. 2003;57(5):1297-1303.
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.57
, Issue.5
, pp. 1297-1303
-
-
Wallner, K.1
Merrick, G.2
True, L.3
Sutlief, S.4
Cavanagh, W.5
Butler, W.6
-
34
-
-
22444442487
-
20 Gy versus 44 Gy supplemental beam radiation with Pd-103 prostate brachytherapy: preliminary biochemical outcomes from a prospective randomized multi-center trial
-
Wallner K, Merrick G, True L, et al. 20 Gy versus 44 Gy supplemental beam radiation with Pd-103 prostate brachytherapy: preliminary biochemical outcomes from a prospective randomized multi-center trial. Radiother Oncol. 2005;75(3):307-310.
-
(2005)
Radiother Oncol
, vol.75
, Issue.3
, pp. 307-310
-
-
Wallner, K.1
Merrick, G.2
True, L.3
-
35
-
-
84858068176
-
Initial report of RTOG 9601, a phase III trial in prostate cancer: effect of anti-androgen therapy (AAT) with bicalutamide during and after radiation therapy (RT) on freedom from progression and incidence of metastatic disease in patients following radical prostatectomy (RP) with pT2-3, N0 disease and elevated PSA levels
-
Shipley WU, Hunt D, Lukka HR, et al. Initial report of RTOG 9601, a phase III trial in prostate cancer: effect of anti-androgen therapy (AAT) with bicalutamide during and after radiation therapy (RT) on freedom from progression and incidence of metastatic disease in patients following radical prostatectomy (RP) with pT2-3, N0 disease and elevated PSA levels. ASCO Meeting Abstracts. 2011;29(suppl 7):1.
-
(2011)
ASCO Meeting Abstracts
, vol.29
, Issue.SUPPL. 7
, pp. 1
-
-
Shipley, W.U.1
Hunt, D.2
Lukka, H.R.3
-
36
-
-
79960227242
-
Radiotherapy and shortterm androgen deprivation for localized prostate cancer
-
Jones CU, Hunt D, McGowan DG, et al. Radiotherapy and shortterm androgen deprivation for localized prostate cancer. N Engl J Med. 2011;365(2):107-118.
-
(2011)
N Engl J Med
, vol.365
, Issue.2
, pp. 107-118
-
-
Jones, C.U.1
Hunt, D.2
McGowan, D.G.3
-
37
-
-
39149085396
-
Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610
-
Roach M III, Bae K, Speight J, et al. Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610. J Clin Oncol. 2008;26(4):585-591.
-
(2008)
J Clin Oncol
, vol.26
, Issue.4
, pp. 585-591
-
-
Roach III, M.1
Bae, K.2
Speight, J.3
-
38
-
-
16344385883
-
Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma-longterm results of phase III RTOG 85-31
-
Pilepich MV, Winter K, Lawton CA, et al. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma-longterm results of phase III RTOG 85-31. Int J Radiat Oncol Biol Phys. 2005;61(5):1285-1290.
-
(2005)
Int J Radiat Oncol Biol Phys
, vol.61
, Issue.5
, pp. 1285-1290
-
-
Pilepich, M.V.1
Winter, K.2
Lawton, C.A.3
-
39
-
-
0642311912
-
Radiation Therapy Oncology Group. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02
-
Hanks GE, Pajak TF, Porter A, et al; Radiation Therapy Oncology Group. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02. J Clin Oncol. 2003;21(21):3972-3978.
-
(2003)
J Clin Oncol
, vol.21
, Issue.21
, pp. 3972-3978
-
-
Hanks, G.E.1
Pajak, T.F.2
Porter, A.3
-
40
-
-
0037674063
-
Radiation Therapy Oncology Group 9413. Phase III trial comparing whole-pelvic versus prostateonly radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413
-
Roach M III, DeSilvio M, Lawton C, et al; Radiation Therapy Oncology Group 9413. Phase III trial comparing whole-pelvic versus prostateonly radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol. 2003;21(10):1904-1911.
-
(2003)
J Clin Oncol
, vol.21
, Issue.10
, pp. 1904-1911
-
-
Roach III, M.1
DeSilvio, M.2
Lawton, C.3
-
41
-
-
0023091042
-
Prognostic factors in carcinoma of the prostate-analysis of RTOG study 75-06
-
Pilepich MV, Krall JM, Sause WT, et al. Prognostic factors in carcinoma of the prostate-analysis of RTOG study 75-06. Int J Radiat Oncol Biol Phys. 1987;13(3):339-349.
-
(1987)
Int J Radiat Oncol Biol Phys
, vol.13
, Issue.3
, pp. 339-349
-
-
Pilepich, M.V.1
Krall, J.M.2
Sause, W.T.3
-
42
-
-
0024227472
-
Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06
-
Asbell SO, Krall JM, Pilepich MV, et al. Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06. Int J Radiat Oncol Biol Phys. 1988;15(6):1307-1316.
-
(1988)
Int J Radiat Oncol Biol Phys
, vol.15
, Issue.6
, pp. 1307-1316
-
-
Asbell, S.O.1
Krall, J.M.2
Pilepich, M.V.3
-
43
-
-
79961126167
-
A randomized trial (Irish clinical oncology research group 97-01) comparing short versus protracted neoadjuvant hormonal therapy before radiotherapy for localized prostate cancer
-
Armstrong JG, Gillham CM, Dunne MT, et al. A randomized trial (Irish clinical oncology research group 97-01) comparing short versus protracted neoadjuvant hormonal therapy before radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2011;81(1):35-45.
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.81
, Issue.1
, pp. 35-45
-
-
Armstrong, J.G.1
Gillham, C.M.2
Dunne, M.T.3
-
44
-
-
79955470908
-
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96. 01 randomised trial
-
Denham JW, Steigler A, Lamb DS, et al. Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial. Lancet Oncol. 2011;12(5):451-459.
-
(2011)
Lancet Oncol
, vol.12
, Issue.5
, pp. 451-459
-
-
Denham, J.W.1
Steigler, A.2
Lamb, D.S.3
-
45
-
-
67149125847
-
EORTC Radiation Oncology Group and Genito-Urinary Tract Cancer Group, Duration of androgen suppression in the treatment of prostate cancer
-
Bolla M, de Reijke TM, Van Tienhoven G, et al; EORTC Radiation Oncology Group and Genito-Urinary Tract Cancer Group. Duration of androgen suppression in the treatment of prostate cancer. N Engl J Med. 2009;360(24):2516-2527.
-
(2009)
N Engl J Med
, vol.360
, Issue.24
, pp. 2516-2527
-
-
Bolla, M.1
de Reijke, T.M.2
Van Tienhoven, G.3
-
46
-
-
4043153049
-
6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial
-
D'Amico AV, Manola J, Loffredo M, Renshaw AA, DellaCroce A, Kantoff PW. 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. JAMA. 2004;292(7):821-827.
-
(2004)
JAMA
, vol.292
, Issue.7
, pp. 821-827
-
-
D'Amico, A.V.1
Manola, J.2
Loffredo, M.3
Renshaw, A.A.4
DellaCroce, A.5
Kantoff, P.W.6
-
47
-
-
58149348673
-
Final report of multicenter Canadian Phase III randomized trial of 3 versus 8 months of neoadjuvant androgen deprivation therapy before conventional-dose radiotherapy for clinically localized prostate cancer
-
Crook J, Ludgate C, Malone S, et al. Final report of multicenter Canadian Phase III randomized trial of 3 versus 8 months of neoadjuvant androgen deprivation therapy before conventional-dose radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2009;73(2):327-333.
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.73
, Issue.2
, pp. 327-333
-
-
Crook, J.1
Ludgate, C.2
Malone, S.3
-
48
-
-
0037072063
-
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
-
Bolla M, Collette L, Blank L, et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet. 2002;360(9327):103-106.
-
(2002)
Lancet
, vol.360
, Issue.9327
, pp. 103-106
-
-
Bolla, M.1
Collette, L.2
Blank, L.3
-
49
-
-
0031403675
-
Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council, trial
-
Medical Research Council Prostate Cancer Working Party Investigators Group
-
Medical Research Council Prostate Cancer Working Party Investigators Group. Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial. Br J Urol. 1997;79(2):235-246.
-
(1997)
Br J Urol.
, vol.79
, Issue.2
, pp. 235-246
-
-
-
50
-
-
0026670427
-
Treatment of advanced localised prostatic cancer by orchiectomy, radiotherapy, or combined treatment A Medical Research Council Study. Urological Cancer Working Party- Subgroup on Prostatic Cancer
-
Fellows GJ, Clark PB, Beynon LL, et al. Treatment of advanced localised prostatic cancer by orchiectomy, radiotherapy, or combined treatment. A Medical Research Council Study. Urological Cancer Working Party- Subgroup on Prostatic Cancer. Br J Urol. 1992;70(3):304-309.
-
(1992)
Br J Urol
, vol.70
, Issue.3
, pp. 304-309
-
-
Fellows, G.J.1
Clark, P.B.2
Beynon, L.L.3
-
51
-
-
33644857333
-
Casodex Early Prostate Cancer Trialists' Group Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer
-
McLeod DG, Iversen P, See WA, Morris T, Armstrong J, Wirth MP; Casodex Early Prostate Cancer Trialists' Group. Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer. BJU Int. 2006;97(2):247-254.
-
(2006)
BJU Int
, vol.97
, Issue.2
, pp. 247-254
-
-
McLeod, D.G.1
Iversen, P.2
See, W.A.3
Morris, T.4
Armstrong, J.5
Wirth, M.P.6
-
52
-
-
58649103315
-
Scandinavian Prostate Cancer Group Study 7/Swedish Association for Urological Oncology 3. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
-
Widmark A, Klepp O, Solberg A, et al; Scandinavian Prostate Cancer Group Study 7/Swedish Association for Urological Oncology 3. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet. 2009;373(9660):301-308.
-
(2009)
Lancet
, vol.373
, Issue.9660
, pp. 301-308
-
-
Widmark, A.1
Klepp, O.2
Solberg, A.3
-
53
-
-
83955165856
-
NCIC CTG PR.3/MRC UK PR07 investigators. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial
-
Warde P, Mason M, Ding K, et al. NCIC CTG PR.3/MRC UK PR07 investigators. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. Lancet. 2011;378(9809):2104-2111.
-
(2011)
Lancet
, vol.378
, Issue.9809
, pp. 2104-2111
-
-
Warde, P.1
Mason, M.2
Ding, K.3
-
54
-
-
77950217230
-
Casodex Early Prostate Cancer Trialists' Group Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years
-
Iversen P, McLeod DG, See WA, Morris T, Armstrong J, Wirth MP; Casodex Early Prostate Cancer Trialists' Group. Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years. BJU Int. 2010;105(8):1074-1081.
-
(2010)
BJU Int
, vol.105
, Issue.8
, pp. 1074-1081
-
-
Iversen, P.1
McLeod, D.G.2
See, W.A.3
Morris, T.4
Armstrong, J.5
Wirth, M.P.6
-
55
-
-
80053065502
-
Prediction of erectile function following treatment for prostate cancer
-
Alemozaffar M, Regan MM, Cooperberg MR, et al. Prediction of erectile function following treatment for prostate cancer. JAMA. 2011;306(11):1205-1214.
-
(2011)
JAMA
, vol.306
, Issue.11
, pp. 1205-1214
-
-
Alemozaffar, M.1
Regan, M.M.2
Cooperberg, M.R.3
-
56
-
-
68849106447
-
Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy
-
Aaronson DS, Yamasaki I, Gottschalk A, et al. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy. BJU Int. 2009;104(5):600-604.
-
(2009)
BJU Int
, vol.104
, Issue.5
, pp. 600-604
-
-
Aaronson, D.S.1
Yamasaki, I.2
Gottschalk, A.3
-
57
-
-
34547828797
-
Radiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients
-
Spiotto MT, Hancock SL, King CR. Radiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients. Int J Radiat Oncol Biol Phys. 2007;69(1):54-61.
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.69
, Issue.1
, pp. 54-61
-
-
Spiotto, M.T.1
Hancock, S.L.2
King, C.R.3
-
58
-
-
79953862243
-
Pelvic nodal radiotherapy in patients with unfavorable intermediate and high-risk prostate cancer: evidence, rationale, and future directions
-
Morikawa LK, Roach M III. Pelvic nodal radiotherapy in patients with unfavorable intermediate and high-risk prostate cancer: evidence, rationale, and future directions. Int J Radiat Oncol Biol Phys. 2011;80(1):6-16.
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.80
, Issue.1
, pp. 6-16
-
-
Morikawa, L.K.1
Roach III, M.2
-
59
-
-
79953841975
-
Diagnostic and therapeutic imaging for cancer: therapeutic considerations and future directions
-
Roach M III, Alberini JL, Pecking AP, et al. Diagnostic and therapeutic imaging for cancer: therapeutic considerations and future directions. J Surg Oncol. 2011;103(6):587-601.
-
(2011)
J Surg Oncol
, vol.103
, Issue.6
, pp. 587-601
-
-
Roach III, M.1
Alberini, J.L.2
Pecking, A.P.3
-
60
-
-
67649978936
-
Predictive models in external beam radiotherapy for clinically localized prostate cancer
-
Roach M III, Waldman F, Pollack A. Predictive models in external beam radiotherapy for clinically localized prostate cancer. Cancer. 2009;115(13 suppl):3112-3120.
-
(2009)
Cancer
, vol.115
, Issue.13 SUPPL.
, pp. 3112-3120
-
-
Roach III, M.1
Waldman, F.2
Pollack, A.3
-
61
-
-
69449091608
-
PET-CT for treatment planning in prostate cancer
-
Picchio M, Crivellaro C, Giovacchini G, Gianolli L, Messa C. PET-CT for treatment planning in prostate cancer. Q J Nucl Med Mol Imaging. 2009;53(2):245-268.
-
(2009)
Q J Nucl Med Mol Imaging
, vol.53
, Issue.2
, pp. 245-268
-
-
Picchio, M.1
Crivellaro, C.2
Giovacchini, G.3
Gianolli, L.4
Messa, C.5
-
62
-
-
35349004770
-
Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer
-
quiz N47-N48
-
Eschmann SM, Pfannenberg AC, Rieger A, et al. Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer. Nuklearmedizin. 2007;46(5):161-168; quiz N47-N48.
-
(2007)
Nuklearmedizin
, vol.46
, Issue.5
, pp. 161-168
-
-
Eschmann, S.M.1
Pfannenberg, A.C.2
Rieger, A.3
-
63
-
-
33745006643
-
11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer
-
Wachter S, Tomek S, Kurtaran A, et al. 11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer. J Clin Oncol. 2006;24(16):2513-2519.
-
(2006)
J Clin Oncol
, vol.24
, Issue.16
, pp. 2513-2519
-
-
Wachter, S.1
Tomek, S.2
Kurtaran, A.3
-
64
-
-
33845351365
-
Value of (11)C-choline PET and PET/ CT in patients with suspected prostate cancer [published online ahead of print August 24 2006]
-
Scher B, Setiz M, Albinger W, et al. Value of (11)C-choline PET and PET/ CT in patients with suspected prostate cancer [published online ahead of print August 24, 2006]. Eur J Nucl Med Mol Imaging. 2007;31(1):45-53.
-
(2007)
Eur J Nucl Med Mol Imaging
, vol.31
, Issue.1
, pp. 45-53
-
-
Scher, B.1
Setiz, M.2
Albinger, W.3
-
65
-
-
33749048518
-
Imaging prostate cancer with 11C-choline PET/CT
-
Reske SN, Blumstein NM, Neumaier B, et al. Imaging prostate cancer with 11C-choline PET/CT. J Nucl Med. 2006;47(8):1249-1254.
-
(2006)
J Nucl Med
, vol.47
, Issue.8
, pp. 1249-1254
-
-
Reske, S.N.1
Blumstein, N.M.2
Neumaier, B.3
-
66
-
-
0038469746
-
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
-
Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003;348(25):2491-2499.
-
(2003)
N Engl J Med
, vol.348
, Issue.25
, pp. 2491-2499
-
-
Harisinghani, M.G.1
Barentsz, J.2
Hahn, P.F.3
-
67
-
-
67449127098
-
Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy
-
Ross RW, Zietman AL, Xie W, et al. Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy. Clin Imaging. 2009;33(4):301-305.
-
(2009)
Clin Imaging
, vol.33
, Issue.4
, pp. 301-305
-
-
Ross, R.W.1
Zietman, A.L.2
Xie, W.3
-
68
-
-
79961129222
-
Comparison of nodal risk formula and MR lymphography for predicting lymph node involvement in prostate cancer
-
Deserno WM, Debats OA, Rozema T, et al. Comparison of nodal risk formula and MR lymphography for predicting lymph node involvement in prostate cancer. Int J Radiat Oncol Biol Phys. 2011;81(1):8-15.
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.81
, Issue.1
, pp. 8-15
-
-
Deserno, W.M.1
Debats, O.A.2
Rozema, T.3
-
69
-
-
83955162988
-
Magnetic resonance lymphography-guided selective high-dose lymph node irradiation in prostate cancer
-
Meijer HJ, Debats OA, Kunze-Busch M, et al. Magnetic resonance lymphography-guided selective high-dose lymph node irradiation in prostate cancer. Int J Radiat Oncol Biol Phys. 2012;82(1):175-183.
-
(2012)
Int J Radiat Oncol Biol Phys
, vol.82
, Issue.1
, pp. 175-183
-
-
Meijer, H.J.1
Debats, O.A.2
Kunze-Busch, M.3
-
70
-
-
49949101872
-
MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study
-
Heesakkers RA, Hövels AM, Jager GJ, et al. MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol. 2008;9(9):850-856.
-
(2008)
Lancet Oncol
, vol.9
, Issue.9
, pp. 850-856
-
-
Heesakkers, R.A.1
Hövels, A.M.2
Jager, G.J.3
|